The urgent need for designing greener drugs

Tomas Brodin*, Michael G. Bertram*, Kathryn E. Arnold, Alistair B.A. Boxall, Bryan W. Brooks, Daniel Cerveny, Manuela Jörg, Karen A. Kidd, Unax Lertxundi, Jake M. Martin, Lauren T. May, Erin S. McCallum, Marcus Michelangeli, Charles R. Tyler, Bob B.M. Wong, Klaus Kümmerer, Gorka Orive*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Abstract

The pervasive contamination of ecosystems with active pharmaceutical ingredients poses a serious threat to biodiversity, ecosystem services and public health. Urgent action is needed to design greener drugs that maintain efficacy but also minimize environmental impact.

Original languageEnglish
Pages (from-to)949-951
Number of pages3
JournalNature Sustainability
Volume7
Issue number8
Early online date5 Jun 2024
DOIs
Publication statusPublished - Aug 2024

Bibliographical note

Publisher Copyright:
© Springer Nature Limited 2024.

Cite this